COVID-19 Pandemic in Brazil: Clinical Manifestation and Effect of Comorbidities on Outcomes of Hospitalized SARI Cases, Mario Keko, Karl E. Peace
Karl E. Peace

COVID-19 Pandemic in Brazil: Clinical manifestation and effect of comorbidities on outcomes of hospitalized SARI cases, Mario Keko, Karl E. Peace
Karl E. Peace

COVID-19 Pandemic in Brazil: Clinical manifestation and effect of comorbidities on outcomes of hospitalized SARI cases, Mario Keko, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations

40 Years of the Biopharmaceutical Section: Celebrating our Past, Planning for our Future, Charles Buncher, Stacy Lindborg, Karl E. Peace, Matilde Sanchez-Kam, Steve Wilson
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations

Informatics and the Covid-19 Crisis: the Role of Information Systems and Clinical Trials Databases, Gulzar H. Shah, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Unplanned Changes in Estimands with Two-Stage Adaptive Designs, Qing Liu, Karl E. Peace
Karl E. Peace

Commentary: Is Informed Consent as Ethical as it Could be?, Karl E. Peace
Karl E. Peace

Fruits and Labors of a Purpose Driven Life, Karl E. Peace
Karl E. Peace

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Karl E. Peace

Improve Membership in the APHA Statistics Section, Karl E. Peace
Karl E. Peace

Foreword by Karl E. Peace, Karl E. Peace
Karl E. Peace

Approval of Drugs in the US – Hitting close to Home, Karl E. Peace
Karl E. Peace

ASU Graduate Symposium to feature distinguished cancer scholar, Karl E. Peace
Karl E. Peace

Approval of Drugs in the USA, Karl E. Peace
Karl E. Peace

Letter to the Editor, Re: Make a Plan and Follow it, Karl E. Peace
Karl E. Peace

Public Health Classroom, J. Grillo, Karl E. Peace
Karl E. Peace

The Pharmaceutical Industry as a Major Player in Public Health, Karl E. Peace
Karl E. Peace

Informatics and the Covid-19 Crisis: the Role of Information Systems and Clinical Trials Databases, Gulzar H. Shah, Karl E. Peace
Gulzar H. Shah Dr.

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study, Karl E. Peace, Jingjing Yin, Haresh Rochani, Sarbesh R. Pandeya, Stanley Young
Haresh Rochani

COVID-19 Pandemic in Brazil: Clinical Manifestation and Effect of Comorbidities on Outcomes of Hospitalized SARI Cases, Mario Keko, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Lili Yu

A Comparison of Two Methods for Generating Data That Follow The Lindley Distribution, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Background, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part III), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part I), Qing Liu, Karl E. Peace
Karl E. Peace

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study, Karl E. Peace, Jingjing Yin, Haresh Rochani, Sarbesh R. Pandeya, Stanley Young
Karl E. Peace

Regression Multiple Imputation for Missing Data Analysis, Lili Yu, Liang Liu, Karl E. Peace
Lili Yu

Statistical Considerations for Clinical Trials During COVID-19: An Adaptive Hybrid Design for Clinical Development in Rare Diseases, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials in Patients with COVID-19 High Risks, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Accurate COVID-19 Testing in Clinical Trials, Stephan Ogenstad, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part II), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials with Chronic Conditions, Qing Liu, Karl E. Peace
Karl E. Peace

Adaptive Design and the Estimand Framework, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part III), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part I), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Independent DMC for Blinded Data Monitoring and Analysis, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Integrated Analysis of Efficacy (IAE) with Adaptive Estimands, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Interim Analysis with Adaptive Estimands Based, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part I), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part III), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part II), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials, Michael T. Tirgan, Qing Liu, Karl E. Peace
Karl E. Peace

Regression Multiple Imputation for Missing Data Analysis, Lili Yu, Liang Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Steps for Mitigation, Qing Liu, Karl E. Peace
Karl E. Peace

Closest Similar Subset Imputation for Missing Data Analysis, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Informatics and the Covid-19 Crisis: the Role of Information Systems and Clinical Trials Databases, Gulzar H. Shah, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part I), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part III), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part II), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Steps for Mitigation, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Regression Multiple Imputation for Missing Data Analysis, Lili Yu, Liang Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Integrated Analysis of Efficacy (IAE) with Adaptive Estimands, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Interim Analysis with Adaptive Estimands Based, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: An Adaptive Hybrid Design for Clinical Development in Rare Diseases, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials with Chronic Conditions, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part I), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part II), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part III), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials in Patients with COVID-19 High Risks, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part III), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Accurate COVID-19 Testing in Clinical Trials, Stephan Ogenstad, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials, Michael T. Tirgan, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Independent DMC for Blinded Data Monitoring and Analysis, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study, Karl E. Peace, Jingjing Yin, Haresh Rochani, Sarbesh R. Pandeya, Stanley Young
Jingjing Yin

Statistical Considerations for Clinical Trials During COVID-19: Background, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part I), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Unplanned Changes in Estimands with Two-Stage Adaptive Designs, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Closest Similar Subset Imputation for Missing Data Analysis, Macaulay Okwuokenye, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Adaptive Design and the Estimand Framework, Macaulay Okwuokenye, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Choosing the Function of Baseline Run-In Data for Use as a Covariate in the Analysis of Treatment Data from Phase III Clinical Trials in Hypertension, Yi Hao, Karl E. Peace
Karl E. Peace

Interesting Applications from Three Decades of Biostatistical Consulting, Karl E. Peace, Uche Eseoghene Okoro, Kao-Tai Tsai
Karl E. Peace

Overview of Time-to-Event Endpoint Methodology, Karl E. Peace
Karl E. Peace

Overview of Parametric Based Inferential Methods for Time-to-Event Endpoints, Karl E. Peace, Kao-Tai Tsai
Karl E. Peace

Time-to-Event Endpoint Methods in Antibiotic Trials, Karl E. Peace
Karl E. Peace

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study, Karl E. Peace, Jingjing Yin, Haresh Rochani, Sarbesh R. Pandeya, Stanley Young
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Interesting Applications from Three Decades of Biostatistical Consulting, Karl E. Peace, Uche Eseoghene Okoro, Kao-Tai Tsai
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Choosing the Function of Baseline Run-In Data for Use as a Covariate in the Analysis of Treatment Data from Phase III Clinical Trials in Hypertension, Yi Hao, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Fruits and Labors of a Purpose Driven Life, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations

A Comparison of Two Methods for Generating Data That Follow The Lindley Distribution, Macaulay Okwuokenye, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations

Improve Membership in the APHA Statistics Section, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Foreword by Karl E. Peace, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Letter to the Editor, Re: Make a Plan and Follow it, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Overview of Parametric Based Inferential Methods for Time-to-Event Endpoints, Karl E. Peace, Kao-Tai Tsai
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Overview of Time-to-Event Endpoint Methodology, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Time-to-Event Endpoint Methods in Antibiotic Trials, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

ASU Graduate Symposium to feature distinguished cancer scholar, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

The Pharmaceutical Industry as a Major Player in Public Health, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Approval of Drugs in the USA, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Approval of Drugs in the US – Hitting close to Home, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Commentary: Is Informed Consent as Ethical as it Could be?, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Public Health Classroom, J. Grillo, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications